Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412555 · ClinicalTrials.gov registry record · Phase 4
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
A Phase 4 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
NCT00412555 is a Phase 4 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 52 participants.
The verdict
NCT00412555, a Phase 4 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is circulating in the community will receive treatment with Tamiflu syrup (or capsules) 30mg-75mg once daily (dependent on body weight) for 6 weeks. Safety data and influenza symptoms will be recorded throughout the study. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.
Interventions
- DRUG oseltamivir [Tamiflu]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00412555
The ClinicalTrials.gov registry entry for NCT00412555 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oseltamivir [Tamiflu] is the first listed.
NCT00412555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00412555 about?
NCT00412555 is a clinical study titled "A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.". This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is circulating in the community will receive treatment with Tamiflu syrup (or capsules) 30mg-75mg once dai...
What is the current status of trial NCT00412555?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2006-12. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00412555?
The interventions under investigation include: oseltamivir [Tamiflu] (DRUG).
Who is sponsoring clinical trial NCT00412555?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.